Get the latest Vertex Pharmaceuticals Incorporated (VRTX) stock news and headlines to help you in your trading and investing decisions.

See the latest Vertex Pharmaceuticals Inc stock price (VRTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Vertex could be closing in on a deal with the NHS over its portfolio of cystic fibrosis drugs, after health ministers wrote to the US firm asking for a conclusion to talks after almost two years ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880.

Review the current valuation for Vertex Pharmaceuticals Inc (VRTX:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

View the most recent data and latest information on option chains for Vertex Pharmaceuticals Incorporated Common Stock (VRTX) at Nasdaq.com.